The Discounted Cash Flow (DCF) valuation of Lattice Biologics Ltd (LBL.V) is 0.01 CAD. With the latest stock price at 0.04 CAD, the upside of Lattice Biologics Ltd based on DCF is -84.4%.

Is LBL.V a buy or a sell?

Based on the latest price of 0.04 CAD and our DCF valuation, Lattice Biologics Ltd (LBL.V) is a sell. Selling LBL.V stocks now will result in a potential gain of 84.4%.

	Range	Selected
WACC / Discount Rate	4.1% - 6.4%	5.3%
Long-term Growth Rate	2.0% - 3.9%	2.9%
Fair Price	0 - 0.03	0.01
Upside	-88.4% - -15.4%	-84.4%

0.04 CAD

Stock Price

0.01 CAD

Fair Price

REVENUE & EXPENSES

CAPEX

D&A

WORKING CAPITAL

TERMINAL VALUE

LBL.V DCF Valuation: Revenue & Expenses Forecast

(USD in millions)		Projections

	09-2020	09-2021	09-2022	09-2023	09-2024	09-2025

Revenue	2	1	1	1	1	2
% Growth	13%	-49%	5%	8%	3%	5%

Cost of goods sold	(1)	(1)	(1)	(1)	(1)	(1)
% of Revenue	59%	56%	53%	50%	48%	45%

Selling, G&A expenses	(1)	(1)	(1)	(1)	(1)	(1)
% of Revenue	46%	46%	46%	46%	46%	46%

Research & Development	0	0	0	0	0	0
% of Revenue	0%	0%	0%	0%	0%	0%

Net interest & other expenses	(1)	(1)	(1)	(1)	(1)	(1)
% of Revenue	55%	55%	55%	55%	55%	55%

Tax expense	0	0	0	0	0	0
Tax rate	0%	27%	27%	27%	27%	27%

Net profit	(1)	(1)	(1)	(1)	(1)	(1)
% Margin	-60%	-42%	-40%	-38%	-36%	-34%